U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C16H17N3S
Molecular Weight 283.391
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DASB

SMILES

CN(C)CC1=CC=CC=C1SC2=CC=C(C=C2N)C#N

InChI

InChIKey=UVWLEPXXYOYDGR-UHFFFAOYSA-N
InChI=1S/C16H17N3S/c1-19(2)11-13-5-3-4-6-15(13)20-16-8-7-12(10-17)9-14(16)18/h3-9H,11,18H2,1-2H3

HIDE SMILES / InChI

Molecular Formula C16H17N3S
Molecular Weight 283.391
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures.
2010-11-23
Cerebral 5-HT2A receptor and serotonin transporter binding in humans are not affected by the val66met BDNF polymorphism status or blood BDNF levels.
2010-11
Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study.
2010-10
Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [11C] DASB binding in the living human brain.
2010-08-01
Cerebral serotonin transporter binding is inversely related to body mass index.
2010-08-01
Mapping of serotonin transporters by positron emission tomography with [11C]DASB in conscious common marmosets: comparison with rhesus monkeys.
2010-08
Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB.
2010-07
Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.
2010-06
Cognitive impact of genetic variation of the serotonin transporter in primates is associated with differences in brain morphology rather than serotonin neurotransmission.
2010-05
A nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: an in vivo molecular imaging study in humans.
2010-03-03
Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV.
2010-02-01
Brain serotonin transporter occupancy by oral sibutramine dosed to steady state: a PET study using (11)C-DASB in healthy humans.
2010-02
Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study.
2010-01-01
Serotonin transporter binding and genotype in the nonhuman primate brain using [C-11]DASB PET.
2009-10-01
Simple and rapid preparation of [11C]DASB with high quality and reliability for routine applications.
2009-09
Utility of small-animal positron emission tomographic imaging of rats for preclinical development of drugs acting on the serotonin transporter.
2009-09
Serotonin transporter availability in the amygdala and bed nucleus of the stria terminalis predicts anxious temperament and brain glucose metabolic activity.
2009-08-12
Altered brain serotonin transporter and associated glucose metabolism in Alzheimer disease.
2009-08
A probabilistic approach to delineating functional brain regions.
2009-06
High familial risk for mood disorder is associated with low dorsolateral prefrontal cortex serotonin transporter binding.
2009-06
Behavioral and neurobiological characteristics influencing social hierarchy formation in female cynomolgus monkeys.
2009-02-18
Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB.
2008-09-15
Seasonal variation in human brain serotonin transporter binding.
2008-09
Effects of citalopram infusion on the serotonin transporter binding of [11C]DASB in healthy controls.
2008-08
Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study.
2008-06
Metabolism and autoradiographic evaluation of [(18)F]FE@CIT: a Comparison with [(123)I]beta-CIT and [(123)I]FP-CIT.
2008-05
Evaluation of non-uniform weighting in non-linear regression for pharmacokinetic neuroreceptor modelling.
2008-02
5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB.
2007-12
Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.
2007-10-15
Relationship between neuroticism personality trait and serotonin transporter binding.
2007-09-15
Effects of increased endogenous serotonin on the in vivo binding of [11C]DASB to serotonin transporters in conscious monkey brain.
2007-09
Human 5-HT transporter availability predicts amygdala reactivity in vivo.
2007-08-22
3-Amino-4-(2-((4-[18F]fluorobenzyl)methylamino)methylphenylsulfanyl)benzonitrile, an F-18 fluorobenzyl analogue of DASB: synthesis, in vitro binding, and in vivo biodistribution studies.
2007-08-21
Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study.
2007-08-15
A PET study of effects of chronic 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on serotonin markers in Göttingen minipig brain.
2007-07
Misunderstandings about how to choose a reference region.
2007-06-01
Effect on [11C]DASB binding after tranylcypromine-induced increase in serotonin concentration: positron emission tomography studies in monkeys and rats.
2007-06
Brain serotonin transporter binding in non-depressed patients with Parkinson's disease.
2007-05
PET [11C]DASB imaging of serotonin transporters in patients with alcoholism.
2007-01
In vivo quantification of serotonin transporters using [(11)C]DASB and positron emission tomography in humans: modeling considerations.
2007-01
Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severity - a [11C]DASB PET study.
2007
Midbrain serotonin transporter binding potential measured with [11C]DASB is affected by serotonin transporter genotype.
2007
Metabolite considerations in the in vivo quantification of serotonin transporters using 11C-DASB and PET in humans.
2006-11
Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography.
2006-08-01
Acute occupancy of brain serotonin transporter by sertraline as measured by [11C]DASB and positron emission tomography.
2006-05-01
The serotonin transporter in rhesus monkey brain: comparison of DASB and citalopram binding sites.
2006-05
Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methods.
2006-05
Effects of early life stress on [11C]DASB positron emission tomography imaging of serotonin transporters in adolescent peer- and mother-reared rhesus monkeys.
2006-04-26
Time course of in vivo 5-HTT transporter occupancy by fluvoxamine.
2006-04
PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method.
2006-02
Patents

Patents

Substance Class Chemical
Created
by admin
on Mon Mar 31 23:30:48 GMT 2025
Edited
by admin
on Mon Mar 31 23:30:48 GMT 2025
Record UNII
PP549Z0645
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BENZONITRILE, 3-AMINO-4-((2-((DIMETHYLAMINO)METHYL)PHENYL)THIO)-
Preferred Name English
DASB
Common Name English
Code System Code Type Description
FDA UNII
PP549Z0645
Created by admin on Mon Mar 31 23:30:48 GMT 2025 , Edited by admin on Mon Mar 31 23:30:48 GMT 2025
PRIMARY
CAS
627490-01-1
Created by admin on Mon Mar 31 23:30:48 GMT 2025 , Edited by admin on Mon Mar 31 23:30:48 GMT 2025
PRIMARY
PUBCHEM
10446567
Created by admin on Mon Mar 31 23:30:48 GMT 2025 , Edited by admin on Mon Mar 31 23:30:48 GMT 2025
PRIMARY
WIKIPEDIA
DASB
Created by admin on Mon Mar 31 23:30:48 GMT 2025 , Edited by admin on Mon Mar 31 23:30:48 GMT 2025
PRIMARY
EPA CompTox
DTXSID001027386
Created by admin on Mon Mar 31 23:30:48 GMT 2025 , Edited by admin on Mon Mar 31 23:30:48 GMT 2025
PRIMARY
Related Record Type Details
BINDER->LIGAND
SALT/SOLVATE -> PARENT